Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/13/2025

Venlafaxine and Polycystic Ovary Syndrome (PCOS)

Introduction to Venlafaxine

  • Venlafaxine has been found effective for managing hot flashes in women, according to the National Comprehensive Cancer Network 1, 2

Prevalence and Pathophysiology of PCOS

  • PCOS affects approximately 4-6% of women in the general population, involving acceleration of pulsatile gonadotropin-releasing hormone (GnRH) secretion, insulin resistance, metabolic dysregulation, and hyperandrogenism 3

Medications Associated with PCOS

  • Valproate has been clearly associated with PCOS in women with epilepsy and bipolar disorder, altering steroidogenesis and affecting sex steroid hormone levels 3

Evaluation and Management of PCOS

  • When evaluating potential medication effects on PCOS, consider medication history, weight changes, and hormonal assessments, including testosterone levels, luteinizing hormone/follicle-stimulating hormone ratio, fasting glucose and insulin levels, and androstenedione levels 3
  • There is no contraindication to using venlafaxine in patients with PCOS, and addressing both psychiatric and endocrine aspects is important for patients with both conditions 1, 2

Monitoring and Recommendations

  • Regular monitoring of metabolic parameters and hormonal status is recommended for patients concerned about medication effects on PCOS, regardless of the specific antidepressant used 1, 2

REFERENCES

1

breast cancer. clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

2

breast cancer risk reduction. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010